Clinical Trials Directory

Trials / Completed

CompletedNCT04839627

Impact of Serum Progesterone Levels on the Day of Fresh and Frozen Embryo Transfer on the Ongoing Pregnancy Rates.

Impact of Serum Progesterone Levels on the Day of Fresh and Frozen Embryo Transfer on the Ongoing Pregnancy Rates

Status
Completed
Phase
Study type
Observational
Enrollment
250 (actual)
Sponsor
Hospital St. Joseph, Marseille, France · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Serum progesterone levels prepare the endometrium for implantation and play an important role during embryo transfer (ET). In clinical practice, luteal phase support progesterone supplementation is systematically offered to all women undergoing medically assisted procreation (AMP), independently of ET conditions (fresh and frozen). The investigators propose to perform a prospective cross-sectional single-center cohort study to measure progesterone levels on the day of the ET on all AMP cycles and to compare these levels between active pregnancies and ET unsuccessful cycles. They will determine progesterone threshold levels corresponding to successful attempts in all ET strategies (fresh and frozen) as well as clinical and biological risk factors leading to luteal phase deficiency during ET. They could therefore individualize progesterone supplementation according to patient's needs.

Conditions

Interventions

TypeNameDescription
OTHERserum progesterone measurementprogesterone levels measurement on the day of the embryo transfer on all AMP cycles

Timeline

Start date
2021-06-16
Primary completion
2023-06-01
Completion
2023-06-01
First posted
2021-04-09
Last updated
2023-08-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04839627. Inclusion in this directory is not an endorsement.